Direct and indirect protection against scabies through ivermectin mass drug administration designed for malaria in Mozambique: a substudy nested within a cluster-randomised, controlled trial.

Saved in:
Bibliographic Details
Title: Direct and indirect protection against scabies through ivermectin mass drug administration designed for malaria in Mozambique: a substudy nested within a cluster-randomised, controlled trial.
Authors: Furnival-Adams J; ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain. Electronic address: joanna.furnivaladams@isglobal.org., Houana A; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique., Saute F; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain., Elobolobo E; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique., Rudd M; ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain., Nicolas P; ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique., Montaña J; ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique., Martinho S; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique., Mundaca H; ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain., Mbanze J; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique., Soares A; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique., Imputiua S; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique., Ruiz-Castillo P; ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain., Ribes M; ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain., Sanz A; ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain., Mamudo Salé M; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique., Macucha A; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique., Casellas A; ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain., Lopez V; Universidad Central de Venezuela, Caracas, Venezuela., Vegove V; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique., Mutepa V; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique., Munguambe H; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique., Xerinda A; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique., Materula F; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique., Rabinovich NR; ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain; Harvard T H Chan School of Public Health, Boston, MA, USA., Engelman D; Tropical Diseases, Murdoch Children's Research Institute, Melbourne, VIC, Australia., Chaccour C; ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain; CIBERINFEC, Madrid, Spain; Navarra Center for International Development, Universidad de Navarra, Pamplona, Spain. Electronic address: cchaccour@unav.es.
Source: The Lancet. Microbe [Lancet Microbe] 2025 Dec; Vol. 6 (12), pp. 101189. Date of Electronic Publication: 2025 Nov 20.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101769019 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-5247 (Electronic) Linking ISSN: 26665247 NLM ISO Abbreviation: Lancet Microbe Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41274299
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Direct and indirect protection against scabies through ivermectin mass drug administration designed for malaria in Mozambique: a substudy nested within a cluster-randomised, controlled trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Furnival-Adams+J%22">Furnival-Adams J</searchLink>; ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain. Electronic address: joanna.furnivaladams@isglobal.org.<br /><searchLink fieldCode="AU" term="%22Houana+A%22">Houana A</searchLink>; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique.<br /><searchLink fieldCode="AU" term="%22Saute+F%22">Saute F</searchLink>; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Elobolobo+E%22">Elobolobo E</searchLink>; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique.<br /><searchLink fieldCode="AU" term="%22Rudd+M%22">Rudd M</searchLink>; ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Nicolas+P%22">Nicolas P</searchLink>; ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique.<br /><searchLink fieldCode="AU" term="%22Montaña+J%22">Montaña J</searchLink>; ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique.<br /><searchLink fieldCode="AU" term="%22Martinho+S%22">Martinho S</searchLink>; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique.<br /><searchLink fieldCode="AU" term="%22Mundaca+H%22">Mundaca H</searchLink>; ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Mbanze+J%22">Mbanze J</searchLink>; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique.<br /><searchLink fieldCode="AU" term="%22Soares+A%22">Soares A</searchLink>; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique.<br /><searchLink fieldCode="AU" term="%22Imputiua+S%22">Imputiua S</searchLink>; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique.<br /><searchLink fieldCode="AU" term="%22Ruiz-Castillo+P%22">Ruiz-Castillo P</searchLink>; ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Ribes+M%22">Ribes M</searchLink>; ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Sanz+A%22">Sanz A</searchLink>; ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Mamudo+Salé+M%22">Mamudo Salé M</searchLink>; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique.<br /><searchLink fieldCode="AU" term="%22Macucha+A%22">Macucha A</searchLink>; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique.<br /><searchLink fieldCode="AU" term="%22Casellas+A%22">Casellas A</searchLink>; ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Lopez+V%22">Lopez V</searchLink>; Universidad Central de Venezuela, Caracas, Venezuela.<br /><searchLink fieldCode="AU" term="%22Vegove+V%22">Vegove V</searchLink>; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique.<br /><searchLink fieldCode="AU" term="%22Mutepa+V%22">Mutepa V</searchLink>; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique.<br /><searchLink fieldCode="AU" term="%22Munguambe+H%22">Munguambe H</searchLink>; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique.<br /><searchLink fieldCode="AU" term="%22Xerinda+A%22">Xerinda A</searchLink>; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique.<br /><searchLink fieldCode="AU" term="%22Materula+F%22">Materula F</searchLink>; Centro de Investigação em Saúde de Manhiça, Mopeia, Mozambique.<br /><searchLink fieldCode="AU" term="%22Rabinovich+NR%22">Rabinovich NR</searchLink>; ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain; Harvard T H Chan School of Public Health, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Engelman+D%22">Engelman D</searchLink>; Tropical Diseases, Murdoch Children's Research Institute, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Chaccour+C%22">Chaccour C</searchLink>; ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain; CIBERINFEC, Madrid, Spain; Navarra Center for International Development, Universidad de Navarra, Pamplona, Spain. Electronic address: cchaccour@unav.es.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101769019%22">The Lancet. Microbe</searchLink> [Lancet Microbe] 2025 Dec; Vol. 6 (12), pp. 101189. <i>Date of Electronic Publication: </i>2025 Nov 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Ltd%22">Elsevier Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101769019 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-5247 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226665247%22">26665247 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Microbe <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41274299
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.lanmic.2025.101189
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 101189
    Titles:
      – TitleFull: Direct and indirect protection against scabies through ivermectin mass drug administration designed for malaria in Mozambique: a substudy nested within a cluster-randomised, controlled trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Furnival-Adams J
      – PersonEntity:
          Name:
            NameFull: Houana A
      – PersonEntity:
          Name:
            NameFull: Saute F
      – PersonEntity:
          Name:
            NameFull: Elobolobo E
      – PersonEntity:
          Name:
            NameFull: Rudd M
      – PersonEntity:
          Name:
            NameFull: Nicolas P
      – PersonEntity:
          Name:
            NameFull: Montaña J
      – PersonEntity:
          Name:
            NameFull: Martinho S
      – PersonEntity:
          Name:
            NameFull: Mundaca H
      – PersonEntity:
          Name:
            NameFull: Mbanze J
      – PersonEntity:
          Name:
            NameFull: Soares A
      – PersonEntity:
          Name:
            NameFull: Imputiua S
      – PersonEntity:
          Name:
            NameFull: Ruiz-Castillo P
      – PersonEntity:
          Name:
            NameFull: Ribes M
      – PersonEntity:
          Name:
            NameFull: Sanz A
      – PersonEntity:
          Name:
            NameFull: Mamudo Salé M
      – PersonEntity:
          Name:
            NameFull: Macucha A
      – PersonEntity:
          Name:
            NameFull: Casellas A
      – PersonEntity:
          Name:
            NameFull: Lopez V
      – PersonEntity:
          Name:
            NameFull: Vegove V
      – PersonEntity:
          Name:
            NameFull: Mutepa V
      – PersonEntity:
          Name:
            NameFull: Munguambe H
      – PersonEntity:
          Name:
            NameFull: Xerinda A
      – PersonEntity:
          Name:
            NameFull: Materula F
      – PersonEntity:
          Name:
            NameFull: Rabinovich NR
      – PersonEntity:
          Name:
            NameFull: Engelman D
      – PersonEntity:
          Name:
            NameFull: Chaccour C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2666-5247
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: The Lancet. Microbe
              Type: main
ResultId 1